Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Assets (2018 - 2026)

TransMedics has reported Assets over the past 8 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Assets rose 32.87% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 32.87%, while the annual FY2025 figure was $1.1 billion, 32.87% up from the prior year.
  • Assets for Q4 2025 was $1.1 billion at TransMedics, up from $946.0 million in the prior quarter.
  • Over five years, Assets peaked at $1.1 billion in Q4 2025 and troughed at $117.3 million in Q2 2022.
  • A 5-year average of $526.6 million and a median of $689.8 million in 2023 define the central range for Assets.
  • Biggest five-year swings in Assets: decreased 17.68% in 2021 and later soared 488.62% in 2023.
  • Year by year, Assets stood at $134.9 million in 2021, then soared by 105.46% to $277.1 million in 2022, then surged by 154.76% to $706.0 million in 2023, then increased by 13.88% to $804.1 million in 2024, then skyrocketed by 32.87% to $1.1 billion in 2025.
  • Business Quant data shows Assets for TMDX at $1.1 billion in Q4 2025, $946.0 million in Q3 2025, and $890.5 million in Q2 2025.